blockchain and cryptocurrency- Top Featured snippets

Central Bank: On December 18th, 20 billion yuan of central bank bills will be issued. On December 18th, the People's Bank of China will issue the 12th issue of central bank bills in 2024 through the CMU bond bidding platform of the Hong Kong Monetary Authority. The 12th central bank bill has a maturity of 6 months (182 days), and is a fixed-rate interest-bearing bond, with a circulation of RMB 20 billion. The value date is December 20, 2024, and the maturity date is June 20, 2025, and the maturity date will be postponed in case of a holiday.People's Government of Minhang District, Shanghai: Helping enterprises to go out and encourage foreign trade enterprises to expand their business. The People's Government of Minhang District issued the Policy Opinions on High-quality Industrial Development in Minhang District (Trial), which pointed out that helping enterprises to go out. Support enterprises to purchase export credit insurance products and build or rent overseas warehouses overseas. Encourage foreign trade enterprises to expand their business and give certain financial support to enterprises that reach a certain scale. Support new energy vehicles, used cars, photovoltaics and other enterprises to expand overseas markets. Support the development of cross-border e-commerce. Support the development, maintenance and system construction of enterprises to build or dock cross-border e-commerce platforms. Encourage enterprises to export business in cross-border e-commerce mode. Encourage enterprises to deeply participate in the creation of the "Silk Road E-commerce" cooperation pioneer zone.South Korea's opposition party once again called on Yin Xiyue to step down. According to Yonhap News Agency, Li Zaiming, leader of the Common Democratic Party, the largest opposition party in South Korea, called on President Yin Xiyue to step down again today (December 12). He believed that the ruling party would vote for the impeachment of President Yin Xiyue and hoped that Yin Xiyue would put everything down as soon as possible. Li Zaiming also called Yin Xiyue on the same day, "Why do 52 million Koreans suffer because of your self-esteem and stubbornness? South Korea's economy is collapsing and its future is being damaged. Who will benefit from it? ! "(CCTV International News)

Aoyuan Group and others were forced to execute 200 million yuan. According to the legal litigation information of Tianyue, recently, Aoyuan Group Co., Ltd. and Zhuhai Aoyuan Huisheng Real Estate Co., Ltd. added one piece of information of the person to be executed, and the execution target was more than 203 million yuan. The enforcement court was Xiangzhou District People's Court of Zhuhai City. Tianyan risk information shows that Aoyuan Group Co., Ltd. has more than 150 pieces of information about executed persons, and the total amount of execution exceeds 14.6 billion yuan. In addition, the company also has a number of consumption restriction orders, the person who has been executed for dishonesty (Lao Lai) and the final case information.Guangxi Securities Regulatory Bureau issued a warning letter to Xinxunda and relevant responsible persons. According to the website of the CSRC, Guangxi Securities Regulatory Bureau issued a decision on taking measures to issue a warning letter to Guangxi Xinxunda Technology Group Co., Ltd. and relevant responsible persons. Among them, it is mentioned that Xinxunda has some problems, such as the occupation of non-operating funds of related parties and the failure to disclose them in time, the failure to review and disclose the external financial assistance in time, and the irregular management of insider registration. The Guangxi Securities Regulatory Bureau decided to issue warning letters to Xinxunda, Wu Chenghua, Wang Fabin, Yan Ming, Chen Gong, Li Yangang and Ye Yanzhen.Long bright technology won an order from the state-owned bank Xinchuang, and recently, long bright technology successfully won an expert order from a state-owned bank for the "Innovation Project of Localization of Bank Card Clearing System".

The European Central Bank may no longer mention the need to adopt a "restrictive" policy to curb inflation. The financial market has completely digested the expectation that the European Central Bank will cut interest rates by 25 basis points on Thursday, and the possibility of a larger rate cut is close to zero. Any adjustment of the ECB's future guidance may be minimal. It may no longer mention the need to adopt "restrictive" policies to curb inflation, which is an implicit signal that interest rates will at least fall to the so-called neutral level. Lorenzo Codogno of LC Macro Advisors said: "In view of the great uncertainties in international geopolitics and policies, it is still appropriate to rely on data and determine the appropriate level and duration of restrictions one after another."The European Central Bank may no longer mention the need to adopt a "restrictive" policy to curb inflation. The financial market has completely digested the expectation that the European Central Bank will cut interest rates by 25 basis points on Thursday, and the possibility of a larger rate cut is close to zero. Any adjustment of the ECB's future guidance may be minimal. It may no longer mention the need to adopt "restrictive" policies to curb inflation, which is an implicit signal that interest rates will at least fall to the so-called neutral level. Lorenzo Codogno of LC Macro Advisors said: "In view of the great uncertainties in international geopolitics and policies, it is still appropriate to rely on data and determine the appropriate level and duration of restrictions one after another."Baolingbao and Fengli Jingqiu reached a strategic cooperation. On December 11th, Baolingbao Biological Co., Ltd. (referred to as "Baolingbao") and Beijing Fengli Jingqiu Pharmaceutical Co., Ltd. (referred to as "Fengli Jingqiu") formally signed an agreement to start the strategic cooperation of lactulose bulk drug products. The two sides will carry out global technology and market expansion in the field of pharmaceutical raw materials.